Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 96

1.

Effects of COMT genotype on sensory gating and its modulation by nicotine: Differences in low and high P50 suppressors.

de la Salle S, Smith D, Choueiry J, Impey D, Philippe T, Dort H, Millar A, Albert P, Knott V.

Neuroscience. 2013 Jun 25;241:147-56. doi: 10.1016/j.neuroscience.2013.03.029. Epub 2013 Mar 25.

2.

Baseline dependency of nicotine's sensory gating actions: similarities and differences in low, medium and high P50 suppressors.

Knott V, de la Salle S, Smith D, Phillipe T, Dort H, Choueiry J, Impey D.

J Psychopharmacol. 2013 Sep;27(9):790-800. doi: 10.1177/0269881113490449. Epub 2013 Jun 6.

PMID:
23744798
3.

The moderating role of the dopamine transporter 1 gene on P50 sensory gating and its modulation by nicotine.

Millar A, Smith D, Choueiry J, Fisher D, Albert P, Knott V.

Neuroscience. 2011 Apr 28;180:148-56. doi: 10.1016/j.neuroscience.2011.02.008. Epub 2011 Feb 16.

4.

Effects of nicotine on the amplitude and gating of the auditory P50 and its influence by dopamine D2 receptor gene polymorphism.

Knott V, Millar A, Fisher D, Albert P.

Neuroscience. 2010 Mar 10;166(1):145-56. doi: 10.1016/j.neuroscience.2009.11.053. Epub 2009 Dec 2.

PMID:
19961902
5.

Differential effects of nicotine on P50 amplitude, its gating, and their neural sources in low and high suppressors.

Knott VJ, Fisher DJ, Millar AM.

Neuroscience. 2010 Oct 27;170(3):816-26. doi: 10.1016/j.neuroscience.2010.07.012. Epub 2010 Jul 17.

PMID:
20643194
6.

Nicotine normalizes event related potentials in COMT-Val-tg mice and increases gamma and theta spectral density.

Cao YA, Featherstone RE, Gandal MJ, Liang Y, Jutzeler C, Saunders J, Tatard-Leitman V, Chen J, Weinberger DR, Lerman C, Siegel SJ.

Behav Neurosci. 2012 Apr;126(2):332-43. doi: 10.1037/a0027047. Epub 2012 Feb 6.

PMID:
22309446
7.

COMT Val108/158Met genotype modulates human sensory gating.

Majic T, Rentzsch J, Gudlowski Y, Ehrlich S, Juckel G, Sander T, Lang UE, Winterer G, Gallinat J.

Neuroimage. 2011 Mar 15;55(2):818-24. doi: 10.1016/j.neuroimage.2010.12.031. Epub 2010 Dec 22.

PMID:
21184832
8.

COMT polymorphism modulates the resting-state EEG alpha oscillatory response to acute nicotine in male non-smokers.

Bowers H, Smith D, de la Salle S, Choueiry J, Impey D, Philippe T, Dort H, Millar A, Daigle M, Albert PR, Beaudoin A, Knott V.

Genes Brain Behav. 2015 Jul;14(6):466-76. doi: 10.1111/gbb.12226. Epub 2015 Jul 15.

9.

Improvement of prepulse inhibition and executive function by the COMT inhibitor tolcapone depends on COMT Val158Met polymorphism.

Giakoumaki SG, Roussos P, Bitsios P.

Neuropsychopharmacology. 2008 Dec;33(13):3058-68. doi: 10.1038/npp.2008.82. Epub 2008 Jun 4.

10.

Schizophrenia-like neurophysiological abnormalities in 22q11.2 deletion syndrome and their association to COMT and PRODH genotypes.

Zarchi O, Carmel M, Avni C, Attias J, Frisch A, Michaelovsky E, Patya M, Green T, Weinberger R, Weizman A, Gothelf D.

J Psychiatr Res. 2013 Nov;47(11):1623-9. doi: 10.1016/j.jpsychires.2013.07.004. Epub 2013 Aug 1.

PMID:
23910792
11.

Association of COMT Val108/158Met genotype with smoking cessation in a nicotine replacement therapy randomized trial.

Johnstone EC, Elliot KM, David SP, Murphy MF, Walton RT, Munafò MR.

Cancer Epidemiol Biomarkers Prev. 2007 Jun;16(6):1065-9.

12.

COMT Val(158)Met genotype determines the direction of cognitive effects produced by catechol-O-methyltransferase inhibition.

Farrell SM, Tunbridge EM, Braeutigam S, Harrison PJ.

Biol Psychiatry. 2012 Mar 15;71(6):538-44. doi: 10.1016/j.biopsych.2011.12.023. Erratum in: Biol Psychiatry. 2015 Feb 1;77(3):304.

13.

The separate and combined effects of monoamine oxidase inhibition and nicotine on P50 sensory gating.

Smith DM, Fisher D, Blier P, Illivitsky V, Knott V.

Psychopharmacology (Berl). 2015 Jun;232(11):1911-20. doi: 10.1007/s00213-014-3823-8. Epub 2014 Dec 4.

PMID:
25466703
14.

Dopamine effects on human error processing depend on catechol-O-methyltransferase VAL158MET genotype.

Mueller EM, Makeig S, Stemmler G, Hennig J, Wacker J.

J Neurosci. 2011 Nov 2;31(44):15818-25. doi: 10.1523/JNEUROSCI.2103-11.2011.

15.

CDP-choline: effects of the procholine supplement on sensory gating and executive function in healthy volunteers stratified for low, medium and high P50 suppression.

Knott V, Smith D, de la Salle S, Impey D, Choueiry J, Beaudry E, Smith M, Saghir S, Ilivitsky V, Labelle A.

J Psychopharmacol. 2014 Dec;28(12):1095-108. doi: 10.1177/0269881114553254. Epub 2014 Oct 14.

PMID:
25315828
16.

Effect of catechol O-methyltransferase val(158)met polymorphism on the p50 gating endophenotype in schizophrenia.

Lu BY, Martin KE, Edgar JC, Smith AK, Lewis SF, Escamilla MA, Miller GA, Cañive JM.

Biol Psychiatry. 2007 Oct 1;62(7):822-5. Epub 2007 Apr 19.

PMID:
17448448
17.

The role of nicotine on respiratory sensory gating measured by respiratory-related evoked potentials.

Chan PY, Davenport PW.

J Appl Physiol (1985). 2010 Mar;108(3):662-9. doi: 10.1152/japplphysiol.00798.2009. Epub 2010 Jan 7.

18.

Association of functional COMT Val108/Met polymorphism with smoking cessation in a nicotine replacement therapy.

Sun H, Guo S, Chen D, Yang F, Zou Y, Di X, Cao Y, Kosten T, Lu L, Zhang XY.

J Neural Transm (Vienna). 2012 Dec;119(12):1491-8. doi: 10.1007/s00702-012-0841-8. Epub 2012 Jun 14.

PMID:
22695756
19.

COMT Val158Met modulates subjective responses to intravenous nicotine and cognitive performance in abstinent smokers.

Herman AI, Jatlow PI, Gelernter J, Listman JB, Sofuoglu M.

Pharmacogenomics J. 2013 Dec;13(6):490-7. doi: 10.1038/tpj.2013.1. Epub 2013 Mar 5.

20.

A preliminary study suggests that nicotine and prefrontal dopamine affect cortico-striatal areas in smokers with performance feedback.

Lee MR, Gallen CL, Ross TJ, Kurup P, Salmeron BJ, Hodgkinson CA, Goldman D, Stein EA, Enoch MA.

Genes Brain Behav. 2013 Jul;12(5):554-63. doi: 10.1111/gbb.12027. Epub 2013 Apr 11.

Items per page

Supplemental Content

Write to the Help Desk